294 related articles for article (PubMed ID: 31868585)
1. MeCP2 nuclear dynamics in live neurons results from low and high affinity chromatin interactions.
Piccolo FM; Liu Z; Dong P; Hsu CL; Stoyanova EI; Rao A; Tjian R; Heintz N
Elife; 2019 Dec; 8():. PubMed ID: 31868585
[TBL] [Abstract][Full Text] [Related]
2. Analysis of protein domains and Rett syndrome mutations indicate that multiple regions influence chromatin-binding dynamics of the chromatin-associated protein MECP2 in vivo.
Kumar A; Kamboj S; Malone BM; Kudo S; Twiss JL; Czymmek KJ; LaSalle JM; Schanen NC
J Cell Sci; 2008 Apr; 121(Pt 7):1128-37. PubMed ID: 18334558
[TBL] [Abstract][Full Text] [Related]
3. Binding of the Rett syndrome protein, MeCP2, to methylated and unmethylated DNA and chromatin.
Hansen JC; Ghosh RP; Woodcock CL
IUBMB Life; 2010 Oct; 62(10):732-8. PubMed ID: 21031501
[TBL] [Abstract][Full Text] [Related]
4. MeCP2 Binding Cooperativity Inhibits DNA Modification-Specific Recognition.
Khrapunov S; Tao Y; Cheng H; Padlan C; Harris R; Galanopoulou AS; Greally JM; Girvin ME; Brenowitz M
Biochemistry; 2016 Aug; 55(31):4275-85. PubMed ID: 27420643
[TBL] [Abstract][Full Text] [Related]
5. Neuronal MeCP2 is expressed at near histone-octamer levels and globally alters the chromatin state.
Skene PJ; Illingworth RS; Webb S; Kerr AR; James KD; Turner DJ; Andrews R; Bird AP
Mol Cell; 2010 Feb; 37(4):457-68. PubMed ID: 20188665
[TBL] [Abstract][Full Text] [Related]
6. MeCP2 Levels Regulate the 3D Structure of Heterochromatic Foci in Mouse Neurons.
Ito-Ishida A; Baker SA; Sillitoe RV; Sun Y; Zhou J; Ono Y; Iwakiri J; Yuzaki M; Zoghbi HY
J Neurosci; 2020 Nov; 40(45):8746-8766. PubMed ID: 33046553
[TBL] [Abstract][Full Text] [Related]
7. MeCP2-E1 isoform is a dynamically expressed, weakly DNA-bound protein with different protein and DNA interactions compared to MeCP2-E2.
Martínez de Paz A; Khajavi L; Martin H; Claveria-Gimeno R; Tom Dieck S; Cheema MS; Sanchez-Mut JV; Moksa MM; Carles A; Brodie NI; Sheikh TI; Freeman ME; Petrotchenko EV; Borchers CH; Schuman EM; Zytnicki M; Velazquez-Campoy A; Abian O; Hirst M; Esteller M; Vincent JB; Malnou CE; Ausió J
Epigenetics Chromatin; 2019 Oct; 12(1):63. PubMed ID: 31601272
[TBL] [Abstract][Full Text] [Related]
8. MeCP2, A Modulator of Neuronal Chromatin Organization Involved in Rett Syndrome.
Martínez de Paz A; Ausió J
Adv Exp Med Biol; 2017; 978():3-21. PubMed ID: 28523538
[TBL] [Abstract][Full Text] [Related]
9. MeCP2 AT-Hook1 mutations in patients with intellectual disability and/or schizophrenia disrupt DNA binding and chromatin compaction in vitro.
Sheikh TI; Harripaul R; Ayub M; Vincent JB
Hum Mutat; 2018 May; 39(5):717-728. PubMed ID: 29431277
[TBL] [Abstract][Full Text] [Related]
10. MeCP2 binds to non-CG methylated DNA as neurons mature, influencing transcription and the timing of onset for Rett syndrome.
Chen L; Chen K; Lavery LA; Baker SA; Shaw CA; Li W; Zoghbi HY
Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5509-14. PubMed ID: 25870282
[TBL] [Abstract][Full Text] [Related]
11. Imaging the binding of MECP2 to DNA.
West AE
Genes Dev; 2023 Oct; 37(19-20):863-864. PubMed ID: 37914350
[TBL] [Abstract][Full Text] [Related]
12. DNA methylation in the gene body influences MeCP2-mediated gene repression.
Kinde B; Wu DY; Greenberg ME; Gabel HW
Proc Natl Acad Sci U S A; 2016 Dec; 113(52):15114-15119. PubMed ID: 27965390
[TBL] [Abstract][Full Text] [Related]
13. Sequence features accurately predict genome-wide MeCP2 binding in vivo.
Rube HT; Lee W; Hejna M; Chen H; Yasui DH; Hess JF; LaSalle JM; Song JS; Gong Q
Nat Commun; 2016 Mar; 7():11025. PubMed ID: 27008915
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic programming of mu-opioid receptor gene in mouse brain is regulated by MeCP2 and Brg1 chromatin remodelling factor.
Hwang CK; Song KY; Kim CS; Choi HS; Guo XH; Law PY; Wei LN; Loh HH
J Cell Mol Med; 2009 Sep; 13(9B):3591-615. PubMed ID: 19602036
[TBL] [Abstract][Full Text] [Related]
15. Impaired in vivo binding of MeCP2 to chromatin in the absence of its DNA methyl-binding domain.
Stuss DP; Cheema M; Ng MK; Martinez de Paz A; Williamson B; Missiaen K; Cosman JD; McPhee D; Esteller M; Hendzel M; Delaney K; Ausió J
Nucleic Acids Res; 2013 May; 41(9):4888-900. PubMed ID: 23558747
[TBL] [Abstract][Full Text] [Related]
16. MeCP2 binds cooperatively to its substrate and competes with histone H1 for chromatin binding sites.
Ghosh RP; Horowitz-Scherer RA; Nikitina T; Shlyakhtenko LS; Woodcock CL
Mol Cell Biol; 2010 Oct; 30(19):4656-70. PubMed ID: 20679481
[TBL] [Abstract][Full Text] [Related]
17. Plasticity at the DNA recognition site of the MeCP2 mCG-binding domain.
Lei M; Tempel W; Chen S; Liu K; Min J
Biochim Biophys Acta Gene Regul Mech; 2019 Sep; 1862(9):194409. PubMed ID: 31356990
[TBL] [Abstract][Full Text] [Related]
18. A mutant form of MeCP2 protein associated with human Rett syndrome cannot be displaced from methylated DNA by notch in Xenopus embryos.
Stancheva I; Collins AL; Van den Veyver IB; Zoghbi H; Meehan RR
Mol Cell; 2003 Aug; 12(2):425-35. PubMed ID: 14536082
[TBL] [Abstract][Full Text] [Related]
19. Affinity for DNA Contributes to NLS Independent Nuclear Localization of MeCP2.
Lyst MJ; Ekiert R; Guy J; Selfridge J; Koerner MV; Merusi C; De Sousa D; Bird A
Cell Rep; 2018 Aug; 24(9):2213-2220. PubMed ID: 30157418
[TBL] [Abstract][Full Text] [Related]
20. A high-resolution imaging approach to investigate chromatin architecture in complex tissues.
Linhoff MW; Garg SK; Mandel G
Cell; 2015 Sep; 163(1):246-55. PubMed ID: 26406379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
